Crawford & Company (CRD-A) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
The annual meeting is scheduled for May 14, 2026, with voting limited to Class B shareholders as of March 17, 2026.
Key agenda items include electing nine directors, amending the 2016 Omnibus Stock and Incentive Plan, and ratifying KPMG LLP as auditor.
The Board recommends voting in favor of all proposals.
The proxy materials and annual report are available online, and shareholders are encouraged to vote by mail, phone, or internet.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors, amending the 2016 Omnibus Stock and Incentive Plan (extending its term to 2032), and ratifying KPMG LLP as the independent auditor for 2026.
The Board unanimously recommends voting FOR all director nominees and both proposals.
Shareholder proposals for the 2027 meeting must be submitted by December 11, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
The Board consists of nine members, with two new appointments since the last meeting.
All directors except the CEO are considered independent under NYSE standards.
Four standing committees: Executive, Audit, Governance, and Compensation and Human Capital.
The Board separates the roles of Chair and CEO to enhance oversight and independence.
Directors are subject to stock ownership guidelines and regular performance reviews.
Latest events from Crawford & Company
- Record segment results and strong cash flow offset lower weather-driven revenue and net income.CRD-A
Q4 20253 Mar 2026 - Q2 net income rose to $8.6M as Broadspire and International Operations offset weather-driven declines.CRD-A
Q2 20242 Feb 2026 - Flat revenue, lower earnings, but Broadspire and International Operations showed strong growth.CRD-A
Q3 202416 Jan 2026 - Q4 revenue up 17% to $347.3M, with record annual revenue but lower net income and cash flow.CRD-A
Q4 20242 Dec 2025 - Board recommends approval of all 2025 proxy items, including new auditor and stock plan amendment.CRD-A
Proxy Filing1 Dec 2025 - Q1 2025 saw 3.4% revenue growth, 139% net income rise, and faces a $5M Q2 tax headwind.CRD-A
Q1 202524 Nov 2025 - Revenue up 2.8% YoY, higher dividend, and improved free cash flow despite lower net income.CRD-A
Q2 202523 Nov 2025 - Q3 net income up 31% with record segment revenues and improved margins; new share buyback approved.CRD-A
Q3 202513 Nov 2025